TM006 Clinical Trial

Huddle presentation

A Phase 2b, Double-blind, Randomized, Placebo-controlled, Multi-center, 16- week Dose-finding, Safety and Efficacy Study with Open-label Extension Period of Tesomet in Adult and Adolescent Subjects with Prader-Willi Syndrome

See if you qualify now, or copy the link and send to someone you know!

See If You Qualify